GE Healthcare Forms Strategic Alliance with FUJIFILM in Life Sciences
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
GE Healthcare, a unit of General Electric Company, announces that it has entered into a Strategic Alliance Agreement with FUJIFILM Corporation.
Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold worldwide under the GE brand in the life science research and drug discovery markets.
“This deal represents an important progression for our business,” stated Yuzo Toda, Director, Corporate Vice President, General Manager of Life Science Products Division, Fujifilm. “By forming the alliance, both companies will make the most of our complementary capabilities to continue to contribute to the advancement of genomic and protein research, and to help enhance the quality of life of people worldwide.”
Toda continued, “GE Healthcare’s global presence as a supplier of reagents and instruments, and its competence in biological applications within the life science field combined with Fujifilm’s leading imaging technologies, R&D and manufacturing capabilities will provide our customers with comprehensive system solutions for research, drug discovery and bioanalytical applications.”
“We are delighted to work with Fujifilm to expand our support to bioscience research in biomolecular imaging system solutions,” said Nigel Darby, General Manager of Biotechnologies, Life Sciences, GE Healthcare. “Fujifilm‘s high quality technology platforms fit well with our proprietary labeling technologies and the adjacent fields in the imaging workflow that GE Healthcare currently addresses. Furthermore, the integration of the imaging platform with our global service organization will give strong and valuable customer support.”
Overview of the alliance:
• Fujifilm will supply image analyzing systems for bioscience research to GE Healthcare, and GE Healthcare will market and sell them under the GE brand.
• GE Healthcare will be responsible for marketing/sales of the systems worldwide, and will provide total solutions including instruments, ECL and DIGE labeling reagents, and applications support. Additionally, GE Healthcare will provide instrument services for the systems.
• Fujifilm and GE Healthcare will collaborate to develop image analyzing systems that are optimized for customer applications.
Under the alliance, Fujifilm will develop, manufacture and supply advanced biomolecular imaging systems to GE Healthcare. The products will be sold worldwide under the GE brand in the life science research and drug discovery markets.
“This deal represents an important progression for our business,” stated Yuzo Toda, Director, Corporate Vice President, General Manager of Life Science Products Division, Fujifilm. “By forming the alliance, both companies will make the most of our complementary capabilities to continue to contribute to the advancement of genomic and protein research, and to help enhance the quality of life of people worldwide.”
Toda continued, “GE Healthcare’s global presence as a supplier of reagents and instruments, and its competence in biological applications within the life science field combined with Fujifilm’s leading imaging technologies, R&D and manufacturing capabilities will provide our customers with comprehensive system solutions for research, drug discovery and bioanalytical applications.”
“We are delighted to work with Fujifilm to expand our support to bioscience research in biomolecular imaging system solutions,” said Nigel Darby, General Manager of Biotechnologies, Life Sciences, GE Healthcare. “Fujifilm‘s high quality technology platforms fit well with our proprietary labeling technologies and the adjacent fields in the imaging workflow that GE Healthcare currently addresses. Furthermore, the integration of the imaging platform with our global service organization will give strong and valuable customer support.”
Overview of the alliance:
• Fujifilm will supply image analyzing systems for bioscience research to GE Healthcare, and GE Healthcare will market and sell them under the GE brand.
• GE Healthcare will be responsible for marketing/sales of the systems worldwide, and will provide total solutions including instruments, ECL and DIGE labeling reagents, and applications support. Additionally, GE Healthcare will provide instrument services for the systems.
• Fujifilm and GE Healthcare will collaborate to develop image analyzing systems that are optimized for customer applications.
